Jundishapur Journal of Microbiology

Published by: Neoscriber Demo Publisher
Crossmark

Effect of Cryptotanshinone on Staphylococcus epidermidis Biofilm Formation Under In Vitro Conditions

Ruiling Zu ORCID 1 , 2 , Hui Yi ORCID 1 , 3 , Yuling Yi ORCID 1 , Jiangyan Yong ORCID 1 and Yan Li ORCID 1 , *
Authors Information
1 School of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China
2 Department of Clinical Laboratory, Sichuan Cancer Hospital and Institute, Chengdu, China
3 Department of Clinical Laboratory, Wenjiang District People's Hospital of Chengdu, Chengdu, China
Article information
  • Jundishapur Journal of Microbiology: April 30, 2019, 12 (4); e83922
  • Published Online: April 27, 2019
  • Article Type: Research Article
  • Received: September 4, 2018
  • Accepted: March 31, 2019
  • DOI: 10.5812/jjm.83922

To Cite: Zu R, Yi H, Yi Y, Yong J, Li Y. Effect of Cryptotanshinone on Staphylococcus epidermidis Biofilm Formation Under In Vitro Conditions, Jundishapur J Microbiol. 2019 ; 12(4):e83922. doi: 10.5812/jjm.83922.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Kuehl R, Brunetto PS, Woischnig AK, Varisco M, Rajacic Z, Vosbeck J, et al. Preventing implant-associated infections by silver coating. Antimicrob Agents Chemother. 2016;60(4):2467-75. doi: 10.1128/AAC.02934-15. [PubMed: 26883700]. [PubMed Central: PMC4808148].
  • 2. Obeng-Nkrumah N, Labi AK, Acquah ME, Donkor ES. Bloodstream infections in patients with malignancies: Implications for antibiotic treatment in a Ghanaian tertiary setting. BMC Res Notes. 2015;8:742. doi: 10.1186/s13104-015-1701-z. [PubMed: 26628056]. [PubMed Central: PMC4667459].
  • 3. Tao F, Jiang R, Chen Y, Chen R. Risk factors for early onset of catheter-related bloodstream infection in an intensive care unit in China: A retrospective study. Med Sci Monit. 2015;21:550-6. doi: 10.12659/MSM.892121. [PubMed: 25695128]. [PubMed Central: PMC4343039].
  • 4. Oliveira WF, Silva PMS, Silva RCS, Silva GMM, Machado G, Coelho L, et al. Staphylococcus aureus and Staphylococcus epidermidis infections on implants. J Hosp Infect. 2018;98(2):111-7. doi: 10.1016/j.jhin.2017.11.008. [PubMed: 29175074].
  • 5. Mekni MA, Bouchami O, Achour W, Ben Hassen A. Strong biofilm production but not adhesion virulence factors can discriminate between invasive and commensal Staphylococcus epidermidis strains. APMIS. 2012;120(8):605-11. doi: 10.1111/j.1600-0463.2012.02877.x. [PubMed: 22779682].
  • 6. Cerca N, Jefferson KK, Oliveira R, Pier GB, Azeredo J. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immun. 2006;74(8):4849-55. doi: 10.1128/IAI.00230-06. [PubMed: 16861673]. [PubMed Central: PMC1539625].
  • 7. Cerca N, Jefferson KK, Maira-Litran T, Pier DB, Kelly-Quintos C, Goldmann DA, et al. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun. 2007;75(7):3406-13. doi: 10.1128/IAI.00078-07. [PubMed: 17470540]. [PubMed Central: PMC1932961].
  • 8. Kristian SA, Birkenstock TA, Sauder U, Mack D, Gotz F, Landmann R. Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. J Infect Dis. 2008;197(7):1028-35. doi: 10.1086/528992. [PubMed: 18419540].
  • 9. Harris LG, Murray S, Pascoe B, Bray J, Meric G, Mageiros L, et al. Biofilm morphotypes and population structure among Staphylococcus epidermidis from commensal and clinical samples. PLoS One. 2016;11(3). e0151240. doi: 10.1371/journal.pone.0151240. [PubMed: 26978068]. [PubMed Central: PMC4792440].
  • 10. Su CY, Ming QL, Rahman K, Han T, Qin LP. Salvia miltiorrhiza: Traditional medicinal uses, chemistry, and pharmacology. Chin J Nat Med. 2015;13(3):163-82. doi: 10.1016/S1875-5364(15)30002-9. [PubMed: 25835361].
  • 11. Xu J, Wei K, Zhang G, Lei L, Yang D, Wang W, et al. Ethnopharmacology, phytochemistry, and pharmacology of Chinese Salvia species: A review. J Ethnopharmacol. 2018;225:18-30. doi: 10.1016/j.jep.2018.06.029. [PubMed: 29935346].
  • 12. Takahashi K, Ouyang X, Komatsu K, Nakamura N, Hattori M, Baba A, et al. Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cells. Biochem Pharmacol. 2002;64(4):745-9. doi: 10.1016/S0006-2952(02)01250-9. [PubMed: 12167494].
  • 13. Maione F, Cantone V, Chini MG, De Feo V, Mascolo N, Bifulco G. Molecular mechanism of tanshinone IIA and cryptotanshinone in platelet anti-aggregating effects: An integrated study of pharmacology and computational analysis. Fitoterapia. 2015;100:174-8. doi: 10.1016/j.fitote.2014.11.024. [PubMed: 25497578].
  • 14. Bissinger R, Lupescu A, Zelenak C, Jilani K, Lang F. Stimulation of eryptosis by cryptotanshinone. Cell Physiol Biochem. 2014;34(2):432-42. doi: 10.1159/000363012. [PubMed: 25095724].
  • 15. Dominguez More GP, Cardenas PA, Costa GM, Simoes CMO, Aragon DM. Pharmacokinetics of botanical drugs and plant extracts. Mini Rev Med Chem. 2017;17(17):1646-64. doi: 10.2174/1389557517666170510112508. [PubMed: 28494732].
  • 16. Jamshidi-Aidji M, Morlock GE. From bioprofiling and characterization to bioquantification of natural antibiotics by direct bioautography linked to high-resolution mass spectrometry: Exemplarily shown for salvia miltiorrhiza root. Anal Chem. 2016;88(22):10979-86. doi: 10.1021/acs.analchem.6b02648. [PubMed: 27766834].
  • 17. Cha JD, Lee JH, Choi KM, Choi SM, Park JH. Synergistic effect between cryptotanshinone and antibiotics against clinic methicillin and vancomycin-resistant Staphylococcus aureus. Evid Based Complement Alternat Med. 2014;2014:450572. doi: 10.1155/2014/450572. [PubMed: 24782909]. [PubMed Central: PMC3982256].
  • 18. Lee DS, Lee SH, Noh JG, Hong SD. Antibacterial activities of cryptotanshinone and dihydrotanshinone I from a medicinal herb, Salvia miltiorrhiza Bunge. Biosci Biotechnol Biochem. 1999;63(12):2236-9. doi: 10.1271/bbb.63.2236. [PubMed: 10664860].
  • 19. Feng H, Xiang H, Zhang J, Liu G, Guo N, Wang X, et al. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cryptotanshinone. J Biomed Biotechnol. 2009;2009:617509. doi: 10.1155/2009/617509. [PubMed: 19707532]. [PubMed Central: PMC2730559].
  • 20. Hui YI, Ruiling ZU, Yuling YI, Yan LI. [Inhibitory effect of cryptotanshinone on biofilm of Staphylococcus epidermidis]. Chin J infect Control. 2017;16(9):798-803. Chinese.
  • 21. Wu Y, Wu Y, Zhu T, Han H, Liu H, Xu T, et al. Staphylococcus epidermidis SrrAB regulates bacterial growth and biofilm formation differently under oxic and microaerobic conditions. J Bacteriol. 2015;197(3):459-76. doi: 10.1128/JB.02231-14. [PubMed: 25404696]. [PubMed Central: PMC4285975].
  • 22. Govantes F. Serial dilution-based growth curves and growth curve synchronization for high-resolution time series of bacterial biofilm growth. Methods Mol Biol. 2018;1734:159-69. doi: 10.1007/978-1-4939-7604-1_13. [PubMed: 29288453].
  • 23. Shi C, Li M, Muhammad I, Ma X, Chang Y, Li R, et al. Combination of berberine and ciprofloxacin reduces multi-resistant Salmonella strain biofilm formation by depressing mRNA expressions of luxS, rpoE, and ompR. J Vet Sci. 2018;19(6):808-16. doi: 10.4142/jvs.2018.19.6.808. [PubMed: 30304890]. [PubMed Central: PMC6265579].
  • 24. Field D, Gaudin N, Lyons F, O'Connor PM, Cotter PD, Hill C, et al. A bioengineered nisin derivative to control biofilms of Staphylococcus pseudintermedius. PLoS One. 2015;10(3). e0119684. doi: 10.1371/journal.pone.0119684. [PubMed: 25789988]. [PubMed Central: PMC4366236].
  • 25. Silva S, Henriques M, Martins A, Oliveira R, Williams D, Azeredo J. Biofilms of non-Candida albicans Candida species: Quantification, structure and matrix composition. Med Mycol. 2009;47(7):681-9. doi: 10.3109/13693780802549594. [PubMed: 19888800].
  • 26. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard. M100. Clinical and Laboratory Standards Institute; 2017.
  • 27. Labthavikul P, Petersen PJ, Bradford PA. In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model. Antimicrob Agents Chemother. 2003;47(12):3967-9. doi: 10.1128/AAC.47.12.3967-3969.2003. [PubMed: 14638511]. [PubMed Central: PMC296180].
  • 28. Macia MD, Rojo-Molinero E, Oliver A. Antimicrobial susceptibility testing in biofilm-growing bacteria. Clin Microbiol Infect. 2014;20(10):981-90. doi: 10.1111/1469-0691.12651. [PubMed: 24766583].
  • 29. Dong Y, Chen S, Wang Z, Peng N, Yu J. Synergy of ultrasound microbubbles and vancomycin against Staphylococcus epidermidis biofilm. J Antimicrob Chemother. 2013;68(4):816-26. doi: 10.1093/jac/dks490. [PubMed: 23248238].
  • 30. Gonzalez-Ramirez AI, Ramirez-Granillo A, Medina-Canales MG, Rodriguez-Tovar AV, Martinez-Rivera MA. Analysis and description of the stages of Aspergillus fumigatus biofilm formation using scanning electron microscopy. BMC Microbiol. 2016;16(1):243. doi: 10.1186/s12866-016-0859-4. [PubMed: 27756222]. [PubMed Central: PMC5069814].
  • 31. Otto M. Molecular basis of Staphylococcus epidermidis infections. Semin Immunopathol. 2012;34(2):201-14. doi: 10.1007/s00281-011-0296-2. [PubMed: 22095240]. [PubMed Central: PMC3272124].
  • 32. Yue J, Yang H, Liu S, Song F, Guo J, Huang C. Influence of naringenin on the biofilm formation of Streptococcus mutans. J Dent. 2018;76:24-31. doi: 10.1016/j.jdent.2018.04.013. [PubMed: 29679633].
  • 33. El-Gharbaoui A, Benitez G, Gonzalez-Tejero MR, Molero-Mesa J, Merzouki A. Comparison of Lamiaceae medicinal uses in eastern Morocco and eastern Andalusia and in Ibn al-Baytar's compendium of simple medicaments (13th century CE). J Ethnopharmacol. 2017;202:208-24. doi: 10.1016/j.jep.2017.03.014. [PubMed: 28323048].
  • 34. Rohde H, Frankenberger S, Zahringer U, Mack D. Structure, function and contribution of polysaccharide intercellular adhesin (PIA) to Staphylococcus epidermidis biofilm formation and pathogenesis of biomaterial-associated infections. Eur J Cell Biol. 2010;89(1):103-11. doi: 10.1016/j.ejcb.2009.10.005. [PubMed: 19913940].
  • 35. Singh VK. High level expression and purification of atl, the major autolytic protein of Staphylococcus aureus. Int J Microbiol. 2014;2014:615965. doi: 10.1155/2014/615965. [PubMed: 24669224]. [PubMed Central: PMC3941666].
  • 36. Yu D, Zhao L, Xue T, Sun B. Staphylococcus aureus autoinducer-2 quorum sensing decreases biofilm formation in an icaR-dependent manner. BMC Microbiol. 2012;12:288. doi: 10.1186/1471-2180-12-288. [PubMed: 23216979]. [PubMed Central: PMC3539994].
  • 37. Niu C, Robbins CM, Pittman KJ, Osborn j L, Stubblefield BA, Simmons RB, et al. LuxS influences Escherichia coli biofilm formation through autoinducer-2-dependent and autoinducer-2-independent modalities. FEMS Microbiol Ecol. 2013;83(3):778-91. doi: 10.1111/1574-6941.12034. [PubMed: 23078586].
  • 38. Singh R, Ray P. Quorum sensing-mediated regulation of staphylococcal virulence and antibiotic resistance. Future Microbiol. 2014;9(5):669-81. doi: 10.2217/fmb.14.31. [PubMed: 24957093].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments